High doses pushed for fast results can stress kidneys and liver
However, mechanistic insight into the interactions among sweeteners, xenobiotics, and gut bacteria remains limited, highlighting the need for accessible in vitro approaches to complement correlative analyses of fecal microbial communities and in vivo models
In a Phase III trial of 886 patients, Keytruda, a PD-1 inhibitor, plus Padcev, an antibody-drug conjugate, reduced the risk of death by 53% over platinum-based chemotherapy
LW RX Wins Same Active Molecule: Both compounded semaglutide (LW RX) and brand-name Wegovy (PlushCare) deliver the same GLP-1 receptor agonist the difference is in price, sourcing, and accessibility
In: Novel applications of long-acting octreotide